$APPH is building indoor vertical farms which I believe is the future of farming and our food supply.
There are dozens of benefits to indoor farming including water efficiency and no pesticides but the number that blew my mind was 30x crop yield per acre versus outdoor farming.
$APPH is operating their first facility in Morehead, KY which is 2.8 million sq feet.
They're already started building their next two facilities in KY and once those are done they'll start building in NY
These facilities will grow tomatoes, peppers, cucumbers and leafy greens.
The company has stated they want 12 facilities up and running by 2025.
I can easily envision a future where $APPH has 50+ facilities all around the country which would cut down on transportation costs and ensure our fruits and veggies are even fresher.
$APPH stock has pulled back nearly 50% over the past two weeks which provides a very attractive entry price in my opinion.
$APPH is one of the only publicly traded certified-B corps which means they are committed to doing good for people & the planet, not just making profits.
I believe that $APPH will quickly become a favorite for ESG investors as they learn more about this company and want to support their mission.
Right now the US is importing close to 50% of our fruits and vegetables from other countries which is unacceptable.
We need to be growing our foods here, pesticide and GMO free, close to the customer and at affordable costs.
$APPH is basically building high-tech greenhouses, packed with sensors and robotics to ensure maximum productivity and efficiency.
$APPH even collects all the rainwater in their 10-acre retention ponds then filters it because circulating it through the closed-loop irrigation system so no water is ever wasted.
I'm also interviewing the Founder & CEO next Thursday.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Here is my recent interview with Thomas Sandgaard, Founder & CEO of @ZynexMedical aka $ZYXI
$ZYXI devices are used for pain management and recovery from injury/surgery -- hopefully instead of opioids
Watch here:
$ZYXI is the leader in electro-stimulation devices and they are 10x better than the crappy ones you buy on Amazon
$ZYXI devices have to be prescribed by a medical professional and given that my entire body hurts most days I'll be visiting my doctor very soon to get one.
$ZYXI is $80+ million in revenues in 2020 which was 76% YoY growth
$ZYXI also has 78% gross margins and is already profitable.
Thomas thinks $ZYXI can do $150M in 2021 and $300M in 2022
$ZYXI doubled the size of their sales force in 2020 and now have 500+ sales people.
Several people have asked me why I'm willing to pay 65x sales for $DMTK - it's a good question so here's my answer:
When you find a company like $DMTK that has the potential to grow revenues at 200% annually for the next 4+ years you don't sit back and wait for it to look cheap.
By the time $DMTK looks cheap it might be a $30+ billion company.
You have to adjust your mindset in you want to invest in these hypergrowth companies that have a smaller revenue base now but massive upside thanks to years of insane growth in the future.
Here are my revenue projections for $DMTK based on their current PLA product, Luminate, PLA+ and several other pipeline products:
Seems like two bad weeks in the markets brings out the worst in some people. It’s too bad b/c I love twitter but some people make it intolerable on certain days. It’s sad that these people have nothing better to do than create fake profiles for the purpose of harassing others.
I have always done my best to provide/create valuable content and help others become better investors.
I’m far from perfect. I don’t have a crystal ball. I make plenty of mistakes like everyone else.
All I can do is try my hardest to find great companies that can deliver strong returns for investors.
I have no idea what these companies will do in the short term. These are companies I want to own for many years.
$DMTK has a bright future. This is going to be a hypergrowth company for the next 3-4 years with current PLA product + Luminate + other genomics skin testing products in the pipeline.
Just wrapped up a great interview with Thomas Sandgaard, Founder & CEO of $ZYXI -- @ZynexMedical
It's insane how undervalued $ZYXI is right now. The company has already given guidance for 2021 revenues around $150M and Thomas thinks they might be able to do $300M in 2022.
With a market cap under $500M this stock is trading at 3x 2021 sales and less than 2x 2022 sales.
Did I mention they have 78% gross margins and are already profitable.
They also have two new products coming to market later this year: 1) blood flow/loss monitor 2) sepsis monitor
It's worth mentioning that Thomas owns 46% of the company so he has more skin in the game than the average Founder or CEO -- I love this.
This interview will be sent to all Substack paid subscribers later today and then my free subscribers will get it later this week.